Seen, Heard, Empowered: What My Visit to Dr. Bard Taught Me About Midlife Health

Introduction

The Women’s Health Collaborative MIDLIFE Health Group is proud to present this powerful firsthand narrative by Sabine Gee, a dedicated Midlife Health & Menopause Coach and passionate advocate for women’s wellness. For years, Sabine has guided countless women over 45 through the complexities of perimenopause, seeking out forward-thinking tools and progressive care strategies that go beyond conventional medicine. Yet it was her long-awaited meeting with Dr. Robert Bard in New York City that would profoundly reshape her clinical perspective.

A pioneer in patient-centered diagnostics and the visionary behind the groundbreaking MenoScan, Dr. Bard offers a refreshingly transparent, hands-on approach to imaging and risk assessment for midlife women. Drawn by a shared commitment to addressing the overlooked and often dismissed symptoms of perimenopause, Sabine sought to experience firsthand how advanced imaging could reveal crucial insights often missed in traditional screenings.

This encounter not only deepened Sabine’s understanding of integrated midlife care but forged a meaningful alliance between two advocates committed to empowering women through proactive, personalized diagnostics. Together, their collaborative mission champions a future where women are seen, heard, and equipped with the knowledge to reclaim agency over their health journey.

"A Personal Journey Into Advanced Midlife Diagnostics
 As a Midlife Health & Menopause Coach, I’m always on the lookout for tools, research, and experts that help women over 45 reclaim their energy, confidence, and health. But sometimes, an experience leaves such a strong impression that it shifts your perspective entirely. That’s exactly what happened during my visit with Dr. Robert Bard in New York City.

Dr. Bard is not your typical radiologist. He is a pioneer in patient-centered diagnostics and the visionary behind the MenoScan—a groundbreaking set of advanced imaging protocols designed to identify hidden risk factors in midlife women. What sets him apart isn’t just the technology he uses, but how he uses it: with the patient, not behind the scenes.

Why I Went
As someone navigating midlife myself, I was curious about the real impact imaging could have on health outcomes—not just for me, but for my clients. I wanted to see what the MenoScan could reveal about my body and how it might complement traditional blood tests.

I was greeted warmly and shown around the office by Dr. Bard himself—a rare experience in today’s medical world. He listened attentively as I shared my health history and specific concerns, then tailored the session to fit my needs.

The Front-Row Experience
What followed was nothing short of remarkable. We began with thermal imaging of my hands and feet—checking for signs of inflammation and arthritic changes. He also performed thermal imaging of my neck and my eye—the latter to assess blood flow to the brain, which is a crucial indicator of brain health. From there, we transitioned to a scan of my neck and carotid artery. With each scan, Dr. Bard explained what we were seeing, in real time.

The most powerful moment? When he examined my thyroid and carotid artery while I sat beside him. The screen was visible to both of us. He explained the health of my thyroid, showed me the blood flow, and answered my questions with care. I felt part of the process. Seen. Heard. Empowered.

Why Imaging Matters
So many midlife women struggle with symptoms they don’t understand: fatigue, weight gain, anxiety, hot flashes. And too often, they’re told it’s all "just aging." But that’s not good enough.

Thyroid health, for example, often goes unchecked beyond a standard blood panel. Yet imaging can detect tissue changes or inflammation well before bloodwork reveals any issues. In fact, Dr. Bard explained that non-invasive tools like elastography and Doppler imaging can even help predict malignancy or rule it out, guiding early intervention.

And when it comes to cardiovascular health, many women are shocked to learn that heart disease is the #1 cause of death post-menopause. While I had recommended calcium scans in the past, I was amazed to learn that Dr. Bard's ultrasound-based scan of the carotid artery can detect early vascular changes even before calcium scans show plaque. This is crucial information for women deciding whether HRT is right for them.

It’s important to note that these are just a few of the many tools included in the comprehensive MenoScan protocol. To explore the full range of what the MenoScan offers, visit: www.menoscan.org

A Diagnostic Revolution
Dr. Bard is revolutionizing how we approach diagnostics. In most U.S. clinics, a technician does the scan, a radiologist reads it later, and the results are then relayed to the patient via yet another doctor—a sharp contrast to what I’m used to in Europe, where each doctor typically performs and interprets their own imaging.

Dr. Bard defies this fragmented model. He holds the probe himself, interprets the scans in real time, and makes the patient an informed partner in the process.

He’s also not afraid of potential litigation or protocols that discourage real-time patient dialogue. Instead, he believes in transparency, empowerment, and human connection—qualities that are sadly rare in modern medicine.

As Dr. Bard says:
"We don't just look for disease. We look for patterns, for early changes, for what might become disease. That's where prevention begins.”

The Future of Midlife Health
The MenoScan is more than a test—it’s a foundation for informed decision-making. Combined with bloodwork and a skilled practitioner, it gives women a full picture of what’s really happening inside their bodies. It highlights the multi-factorial nature of menopause: how hormones, cardiovascular function, thyroid health, inflammation, and even mental well-being are interconnected.

Too often, women are prescribed antidepressants during perimenopause when the real issue is hormonal fluctuation. Too often, they’re told “nothing is wrong,” or that symptoms are "just part of aging."

But as I always say: "The ones with symptoms are the lucky ones.”

Because at least their bodies are speaking up, prompting women to look for solutions, so they can take charge of their health and a healthy, active & joyful next chapter. Let’s stop brushing off women’s symptoms. Let’s start offering them real answers, powerful tools, and a seat at the table when it comes to their own health. Thanks to Dr. Bard, I left not only reassured but equipped—with knowledge, images, and insight I could use to take the next step in my health journey. Every woman deserves this.

___________________________________________________________________________________

Epilogue: Building Bridges for Women’s Health Advancement

By: Dr. Barbara Bartlik & Marilyn Abrahamson

In today’s complex healthcare landscape, meaningful change rarely happens in isolation. True progress is born from collaboration—when medical pioneers, health coaches, patient advocates, and wellness professionals join forces in pursuit of a common goal. This narrative reflects the growing importance of building bridges between clinical experts like Dr. Robert Bard and passionate non-medical professionals like Sabine Gee, whose firsthand insights into the lived experiences of midlife women enrich the dialogue around care.

Click to see the full results of this event

Forging these alliances is essential in the ongoing crusade for better education, advocacy, and diagnostic innovation. Women navigating perimenopause and beyond deserve a healthcare model where expertise is shared, silos are dismantled, and new ideas flourish. By networking across disciplines, we foster environments where groundbreaking technologies like the MenoScan reach those who need them most—and where women’s health concerns are met with real solutions, not dismissive platitudes.

The Women’s Health Collaborative MIDLIFE Health Group stands as a testament to this mission. Together, we amplify each other’s work, validate women’s experiences, and accelerate the movement toward comprehensive, patient-centered care. The future of midlife health belongs to those who are bold enough to build it together.

Common History of Patients Who Benefit from Imaging

Written By: Dr. Robert L. Bard | Edited by: Graciella Davi

Introduction
Advancements in diagnostic imaging have transformed the way clinicians approach complex, multisystem diseases, especially those with subtle or overlapping symptoms. This review presents a case study highlighting the integrative role of advanced imaging modalities in detecting and managing thyroid abnormalities and associated cardiovascular conditions in a perimenopausal patient. A female in her late 40’s with borderline laboratory results, unexplained weight gain, and elevated blood pressure serves as the clinical focus for this comprehensive diagnostic workup.

The initial thyroid sonogram, a cornerstone in endocrine evaluation, identified abnormalities requiring further functional and structural imaging. Technologies such as Doppler imaging, 3D volume histogram analysis, elastography, and spectroscopy were employed to define tissue characteristics, vascular flow, and fibrotic changes. Concurrently, thermology and microvascular mapping revealed evidence of cardiovascular involvement, prompting a broader physiologic assessment.

The article further discusses the emerging connection between endocrine and cardiovascular dysfunctions in perimenopausal women, exploring the diagnostic potential of non-invasive thermal imaging and AI-enhanced technologies. It also emphasizes the value of integrative, real-time imaging techniques in differentiating inflammation from malignancy and guiding therapeutic decisions. These evolving modalities represent the future of personalized, precision medicine in diagnosing and managing chronic inflammatory, vascular, and oncologic diseases.

Routine thyroid sonograms begin with bilateral transverse and longitudinal views. If abnormalities are detected, additional modalities such as functional Doppler imaging, 3D volume histogram, M-mode tissue signature scan, 405nm spectroscopy, microvascular mapping, thermology, and elastography may be employed.

Fig. 1 - In the transverse scan of the left thyroid gland, the initial contact echoes originate from the dermis (moderately echogenic), followed by subcutaneous tissue (echo poor), and linear fascial tissue overlying the deeper muscle layer. The trachea (with two cartilage rings), thyroid gland, and cross-section of the common carotid artery are labeled. The upper lobe demonstrates an echo-poor medial pattern, while the lateral segment retains a normal, moderately echogenic texture.

Due to multiple abnormalities, advanced diagnostic imaging was utilized:

• Functional Doppler imaging revealed decreased blood flow in both lobes.
• 3D volume histogram mapped the extent of fibrotic regions.
• M-mode tissue signature scan quantified poor sound penetration due to scarring.
• 405nm spectroscopy ruled out bacterial disease.
• Microvascular mapping provided a treatment guide.
• Thermology with strain elastography outlined the borders of poorly functioning tissue.
• Shear wave elastography (SWE) quantified the degree of fibrosis, aiding therapeutic planning.

CARDIOVASCULAR SYSTEM ASSESSMENT
As evidence of cardiovascular involvement emerged, further evaluation with thermologic modalities was pursued. Thermology is a non-invasive physiologic and biologic assessment of the cardiovascular system, employing autonomic stress to provoke functional changes — much like a stress test. Hemodynamic challenges are visualized, guiding the physician to identify the most vulnerable anatomic areas.

The value of this technology in cardiovascular screening was noted serendipitously during breast cancer investigations, where abnormal carotid artery circulation in the neck was detected. Similarly, while scanning facial skin for psoriasis and rosacea, notable differences in post-stress physiologic blood flow images were observed. Concussion patients also demonstrated functional distortions in orbital circulation symmetry, correlating with increased intracranial pressure from slowly developing post-traumatic subdural hematomas.

Detecting Perimenopausal Cardiovascular Disease (CVD)
While reviewing the medical history from an anomalous breast examination, a connection to underlying cardiac dysfunction was uncovered.  Elastography documents fibrosis (Fig 3,5) and even identified post-viral myocarditis and post-vaccine cardiac reactions more recently.  

While chronic heart failure in women is reliably diagnosed through echocardiography and EKG, the subtle, silent nature of early arterial stenosis and cardiomyopathy presents a clinical dilemma — one that may be addressed with AI-enhanced thermal screening technologies.

The Future
The development of a non-invasive, cost-effective, and quantitative tool for CVD screening holds promise. Conditions such as endometriosis, inflammatory diseases (like psoriasis), and arteritis (Fig. 2, 4) may benefit from ultrasound elastography’s capacity to detect vascular inflammation.

Therapeutic Advances
Emerging strategies now combine thermal imaging, epigenetic analysis, and microvascular/photoacoustic ultrasound — a diagnostic platform capable of differentiating malignancies from inflammation, while quantitatively assessing metastatic potential in real time. This capability allows for on-the-spot evaluation of treatment efficacy. This innovation is particularly impactful in melanoma care, where aggressive tumors are highly vascular and thermally active. Intriguingly, successfully treated tumors may enlarge as they necrose — a feature now trackable through these technologies. Such advancements are expected to expand into managing diseases like psoriasis, endometriosis, thyroiditis, lupus, and Lyme disease, alongside non-surgical bioenergy therapies.

Conclusion
This case study underscores the vital role of advanced, multimodal imaging in the early detection and management of complex, multisystem conditions, particularly in perimenopausal women who often present with subtle or atypical clinical findings. Through the integration of conventional ultrasound with advanced technologies such as Doppler imaging, 3D volume histograms, M-mode tissue analysis, spectroscopy, elastography, and thermology, a comprehensive diagnostic picture was established. These imaging modalities not only identified structural thyroid abnormalities but also revealed functional vascular impairments and early cardiovascular involvement.

The findings highlight the evolving connection between endocrine dysfunction, inflammatory disease, and cardiovascular risk in midlife women — a demographic often underrepresented in cardiovascular research. Additionally, the potential of AI-enhanced thermal imaging and photoacoustic ultrasound to distinguish inflammation from malignancy and to quantify metastatic activity in real time represents a significant advancement in personalized medicine.

As diagnostic imaging continues to evolve, integrating physiologic, metabolic, and structural assessments will enable earlier detection, more precise characterization of disease processes, and the ability to monitor treatment efficacy non-invasively. This multidisciplinary, technology-driven approach promises to improve outcomes not only in oncology but also in chronic inflammatory and vascular diseases that remain challenging to detect in their earliest stages.

__________________________________________________________________________________

ABOUT THE AUTHOR-

ROBERT L. BARD, MD, PC, DABR, FASLMS - Advanced Imaging & Diagnostic Specialist

Having paved the way for the study of various cancers both clinically and academically, Dr. Robert Bard co-founded the 9/11 CancerScan program to bring additional diagnostic support to all first responders from Ground Zero. His main practice in midtown, NYC (Bard Diagnostic Imaging- www.CancerScan.com) uses the latest in digital Imaging technology has been also used to help guide biopsies and in many cases, even replicate much of the same reports of a clinical invasive biopsy. Imaging solutions such as high-powered Sonograms, Spectral Doppler, sonofluoroscopy, 3D/4D Image Reconstruction and the Spectral Doppler are safe, noninvasive, and does not use ionizing radiation. It is used as a complement to find anomalies and help diagnose the causes of pain, swelling and infection in the body’s internal organs while allowing the diagnostician the ability to zoom and ‘travel’ deep into the body for maximum exploration.

....................................................................................................................................................................

A VOICE FROM THE COMMUNITY

Kudos to Dr. Bard for his groundbreaking work with MenoScan, a diagnostic innovation that is transforming how menopause is understood, diagnosed, and managed. By addressing the intricate interplay of hormonal balance, bone density, cardiovascular function, neurological health, and overall metabolic stability, MenoScan empowers both patients and physicians to make informed, personalized decisions around prevention and care.

In collaboration with Dr. Angela Mazza—a triple board-certified endocrinologist and founder of the Metabolic Center for Wellness—Dr. Bard has assembled a team of leading medical experts dedicated to a comprehensive, individualized approach to women’s health during midlife and beyond. Dr. Mazza’s work highlights the importance of personalized thyroid care, particularly during the menopausal transition. As the accompanying graphic illustrates so clearly, menopause impacts all women. Understanding it fully is essential to improving care and outcomes.

- ROBERTA MORRIS, Menopause Educator l Neuro-Nutrition Specialist

Alzheimer’s Disease: One Woman’s Journey to Helping Women Redefine Their Midlife

Written by: Roberta Morris, Wellness Coach, CHHC, AADP, CC                                                                                                              

Imagine a world where someone you love is right beside you—but no longer truly present. Now, picture being just 8 years old, and that person is your grandmother… someone you adored. Suddenly, you can no longer talk to her, share those special moments, or childhood secrets. The hugs and kisses you once cherished are gone.

My grandmother lived with us. We shared many cherished moments before I turned eight. She usually cooked our meals, but our Friday night dinners were special. As she prepared the food for that evening, I would stand on a stool beside her, watching closely as she worked. For dessert, my grandmother would always bake two apple pies: one large enough for the entire family and the other, a smaller version that she claimed was "prepared" by me. I can still remember looking up at her, smiling with pride and feeling the warmth of our bond. 

Then, one day, everything changed. My grandmother was still with us, but her memory began to fade. Before long, she no longer recognized me. Just like that, all those cherished moments ended abruptly.

My grandmother was diagnosed with cerebral arteriosclerosis, commonly referred to as hardening of the arteries in the brain. Limited information was available about this condition. Subsequent research identified it as a form of Alzheimer’s disease. At that time, the medical understanding of the pathology and progression of Alzheimer's was still in its early developmental stages.

Staying informed on emerging research and advancements in the field over the years ultimately led me to become an advocate for the Alzheimer’s Association. One critical insight shaped the direction of my work: biological differences place women at a significantly higher risk for Alzheimer’s than men. Already a wellness expert, this knowledge strengthened my commitment to supporting women, particularly those transitioning through menopause.

Each year, over a million women enter menopause, yet the transition itself remains widely misunderstood. A persistent lack of education and support—compounded by the stigma surrounding aging—leaves many women believing their productive years are behind them. When open conversations about menopause are avoided, even with friends, family, or healthcare providers, managing symptoms becomes especially challenging.

The scope of my practice is to help women recognize that while their reproductive years may have ended, their productive, vibrant years are far from over. With the right information, encouragement, and lifestyle habits, they can feel empowered, healthy, and confident. Often, this journey begins with a clear explanation of what menopause is, including its stages and common experiences. From there, we shift the focus to the role a healthy lifestyle plays in thriving through this new phase of life.

MENOPAUSE OCCURS IN THREE DISTINCT PHASES

Perimenopause: This transitional stage begins when menstrual cycles become irregular and other menopause-related symptoms, such as hot flashes, night sweats, and mood swings, first emerge. This phase continues up to and includes the point of menopause, which is officially marked by 12 consecutive months without a menstrual period. 

Menopause: Signifying the end of menstruation and natural fertility, menopause is a normal biological process triggered by the gradual decline in ovarian function and a significant drop in hormone levels, especially estrogen.

Post-Menopause: This phase begins after menopause and lasts for the rest of a woman’s life. Although most menopausal symptoms tend to subside during post-menopause, some mild symptoms may persist for several years.

Menopause, while a natural biological transition in a woman's life, marks a critical period when the body becomes more susceptible to a range of health challenges. Although many chronic conditions—such as cardiovascular disease, breast cancer, osteoporosis, diabetes, and genitourinary syndrome of menopause (GSM)—may begin developing years before symptoms appear, menopause can hasten their progression.

During her interview on TED Talk Radio Hour hosted by Manoush Zomorodi, Lisa Mosconi, PhD, Neuroscientist, emphasized that menopause is not merely the end of menstruation, but also encompasses profound changes in the brain — affecting its structure, function, and biochemistry. “The health of the ovaries is linked to the health of the brain and the other way around. At the same time, hormones like estrogen are not only involved in reproduction but also in brain function. And estrogen in particular, or estradiol, is really key for energy production in the brain. At the cellular level, estrogen literally pushes neurons to burn glucose to make energy. If your estrogen is high, your brain energy is high. When your estrogen declines, though, your neurons start slowing down and age faster. For women, brain energy is usually fine before menopause, but then it gradually declines during the transition. And this was found independent of age. It didn't matter if the women were 40, 50, or 60. What mattered most was that they were in menopause.”

The gut-brain connection is a sophisticated, two-way communication pathway linking the brain and digestive system—each deeply affecting the other. This vital relationship, known as the gut-brain axis, becomes especially significant for women navigating menopause. By nourishing the gut with supportive, nutrient-rich foods, she can enhance brain function and cognitive wellbeing.

Making healthy lifestyle choices during the menopause transition may help control a woman’s symptoms and slow the progression of disease.

Quality Sleep: Hormonal fluctuations during menopause may significantly disrupt the sleep cycle, often leading to insomnia. Mood swings and heightened anxiety may also keep women awake. Coupled with the discomfort of night sweats, sleep may feel elusive during this life stage.

Establishing a consistent sleep routine becomes essential for managing these challenges. Simple adjustments—such as creating a regular sleep schedule, reducing screen time, and avoiding strenuous exercise before bedtime—may make falling and staying asleep easier.

Balanced Nutrition:  The Mediterranean lifestyle encompasses more than just diet. Daily physical activity and sharing meals with others are vital components. Together, they may profoundly influence mood and mental health, fostering a deep appreciation for the enjoyment of consuming healthy and delicious foods.

Incorporating dairy products, healthy fats, whole grains, fruits, vegetables, foods rich in phytoestrogens, antioxidants, and high-quality protein into your diet may help alleviate some menopause symptoms. As your body undergoes significant changes during menopause, incorporating adequate essential nutrients like protein and fiber is especially important. A Mediterranean diet—rich fresh produce, nuts, fish, and olive oil—may also play a crucial role in reducing the risk of serious health issues.

Physical Activity:  Menopause affects each woman differently. Regular physical activity may be a powerful ally during menopause, helping to reduce stress and ease common symptoms. Embracing a more active lifestyle may also contribute to long-term health by lowering the risk of age-related conditions. Set realistic goals. Consider walking, gardening, or strength training—whatever keeps you motivated!  

Effective Stress Management:  Hormonal shifts during perimenopause and menopause may intensify the stress response, often leading to anxiety, low mood, and feelings of overwhelm. Chronic stress—fueled by a poor diet, conflict, or constant worry—raises cortisol levels, which can trigger fatigue, brain fog, insomnia, heightened menopause symptoms, and increase the risk of heart disease, stroke, and diabetes. Managing stress is essential, and simple practices like meditation, breathing exercises, walking, journaling, or engaging in hobbies such as reading or gardening can make a powerful difference in restoring balance and well-being.  

Incorporating healthy lifestyle habits—such as quality sleep, balanced nutrition, regular physical activity, and effective stress management—can significantly impact the menopause transition. These choices may help alleviate symptoms and slow the progression of age-related diseases, promoting long-term health and well-being.

Ted Radio Hour, NPR: “Menopause brain’ is a real thing. Here's what to do about it.”  NPR: TED Radio Hour. Manoush Zomorodi, Host, Nov 11, 2022. https://www.npr.org/transcripts/973805003

Mosconi, L., Rahman, A., Diaz, I., et al. (2021). “Perimenopause and emergence of an Alzheimer’s bioenergetic phenotype in brain and periphery.” https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0185926

Sayón-Orea, C., Santiago, S, et al.(2015). “Adherence to Mediterranean dietary pattern and menopausal symptoms in relation to overweight/obesity in Spanish perimenopausal and postmenopausal women.“ https://journals.lww.com/menopausejournal/abstract/2015/07000/adherence_to_mediterranean_dietary_pattern_and.13.aspx

Safabakhsh, M., Siassi, F., et al. (2020). “ Higher intakes of fruits and vegetables are related to fewer menopausal symptoms: a cross-sectional study.” https://journals.lww.com/menopausejournal/abstract/2020/05000/higher_intakes_of_fruits_and_vegetables_are.15.aspx

Erdelyi, A., Tuu, L., et al. (2023). “The Importance of Nutrition in Menopause and Perimenopause—A Review.” https://pmc.ncbi.nlm.nih.gov/articles/PMC10780928/

Peters, B. A., Santoro, N., et al (2022). “Spotlight on the Gut Microbiome in Menopause: Current Insights.” https://pmc.ncbi.nlm.nih.gov/articles/PMC9379122/

“Mayo Clinic Minute: Managing sleep during menopause.” Mayo Clinic News Network. Sonya Goins, Author. Oct 18, 2023. https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-minute-managing-sleep-during-menopause/

Dąbrowska-Galas M., Ptaszkowski K., et al. (2019). “High Physical Activity Level May Reduce Menopausal Symptoms.” https://pmc.ncbi.nlm.nih.gov/articles/PMC6722698/

Taylor-Swanson, L., Wong, A.E., et al. (2018). “The Dynamics of Stress and Fatigue across Menopause: Attractors, Coupling and Resilience.” https://pmc.ncbi.nlm.nih.gov/articles/PMC5866170/

____________________________________________________________________________________________________

ABOUT THE AUTHOR

ROBERTA MORRIS is a wellness expert, neuro-nutrition specialist, and founder of Roberta M…Women Redefining Midlife, a platform devoted to helping women navigate menopause and beyond with confidence and clarity. After entering this life stage unprepared, Roberta made it her mission to break the stigma by providing education, holistic counseling, and workplace consultation. Her signature program, It’s My Turn, empowers women to manage the physical, emotional, and lifestyle changes of midlife—reclaiming their vitality. As a passionate advocate for menopause inclusivity in the workplace, she helps organizations create supportive, health-forward environments for women. Roberta’s lifelong commitment to wellness is grounded in the pillars of nutrition, sleep, movement, and stress management. After witnessing her grandmother’s decline from Alzheimer’s, Roberta became an ambassador advocate for the Alzheimer’s Association. One critical insight: biological differences place women at a significantly higher risk for Alzheimer’s than men—this realization deepened her commitment to supporting women through midlife transitions.

____________________________________________________________________________________________________

INSPIRATION FROM A FELLOW MIDLIFE COACH

"Thank you, Roberta, for your powerful and deeply personal article highlighting the connection between menopause and brain health. Your story about your grandmother touched me deeply — and your explanation of how the decline in estrogen impacts our brain is one every woman deserves to hear. So often, I still hear women say, “Oh, I don’t really have symptoms,” or “I’m through it.” And silently, I panic — not because I want to scare them, but because I want them to understand: it’s not just about managing the short-term symptoms. It’s about protecting our long-term health — our hearts, bones, metabolism, and yes, our brains.

Your work is so beautifully aligned with mine. Helping women understand what’s going on and guiding them to make lifestyle changes now is how we set the stage for a vibrant, healthy, and clear-minded 30+ years ahead.  This is why we act now. Thank you for your ongoing advocacy and your compassionate voice in redefining midlife for women everywhere." 

- By Sabine Gee, Midlife Health & Menopause Expert 

Copyright Notice: The materials provided on this website/web-based article are copyrighted and the intellectual property of the publishers/producers (MENO-NEWS / IntermediaWorx inc. and The AngioFoundation). It is provided publicly strictly for informational purposes within non-commercial use and not for purposes of resale, distribution, public display or performance. Unless otherwise indicated on this web based page, sharing, re-posting, re-publishing of this work is strictly prohibited without due permission from the publishers.  Also, certain content may be licensed from third-parties. The licenses for some of this Content may contain additional terms. When such Content licenses contain additional terms, we will make these terms available to you on those pages (which his incorporated herein by reference).The publishers/producers of this site and its contents such as videos, graphics, text, and other materials published are not intended to be a substitute for professional medical advice, diagnosis, or treatment. For any questions you may have regarding a medical condition, please always seek the advice of your physician or a qualified health provider. Do not postpone or disregard any professional medical advice over something you may have seen or read on this website. If you think you may have a medical emergency, call your doctor or 9-1-1 immediately.  This website does not support, endorse or recommend any specific products, tests, physicians, procedures, treatment opinions or other information that may be mentioned on this site. Referencing any content or information seen or published in this website or shared by other visitors of this website is solely at your own risk. The publishers/producers of this Internet web site reserves the right, at its sole discretion, to modify, disable access to, or discontinue, temporarily or permanently, all or any part of this Internet web site or any information contained thereon without liability or notice to you.

   

   

BEYOND HORMONES (part 2): A Functional Blueprint for Cardiometabolic Health in Menopause

By Hwaida Hannoush, MD FASE 

ADVANCED CARDIOMETABOLIC ASSESSMENT IN MENOPAUSE

A comprehensive functional evaluation includes:

1.     Metabolic Markers
• Fasting insulin, HOMA-IR
• Triglyceride-glucose index (TyG)

• Triglyceride-HDL  index (TyHDL )

·       Adiponectin and leptin: Hormones linked to insulin sensitivity and adipose tissue inflammation.

·       Uric acid: Elevated levels correlate with metabolic syndrome and CVD risk, especially in postmenopausal women.

 

2. Lipid and Particle Analysis
    • ApoB (superior to LDL-C for predicting atherogenic particle burden)
    • Lipoprotein(a) [Lp(a)]: Elevated post-menopause and minimally responsive to statins
    • Oxidized LDL (oxLDL)

·       Advanced NMR lipoprotein subfractionation: For particle size and number

 

3. Inflammatory and Immune Biomarkers
    • hs-CRP, fibrinogen , MPO, Lp-PLA2
    • autoimmune markers (ANA, thyroid antibodies)
    • IL-6 and TNF-α (in select high-risk cases)

·       Galectin-3 in high-risk or HFpEF-prone women.

4. Endocrine and Hormonal Dynamics

    • Estradiol, progesterone, testosterone, and cortisol
    • Full Thyroid panel (TSH, free T3/T4, reverse T3, thyroid antibodies)

 

5. Vascular Imaging and Function                                                                                             

    • CAC score: Critical in identifying subclinical plaque in asymptomatic women
    • Coronary CT Angiography with Flow Reserve (FFR-CT):Coronary CT angiography with fractional flow reserve (FFR-CT) is a non-invasive imaging modality that combines high-resolution anatomical visualization of the coronary arteries with computational assessment of blood flow dynamics. It not only evaluates flow-limiting lesions but also characterizes plaque morphology—distinguishing between soft, mixed, and calcified plaque. Identifying high-risk, non-calcified (soft) plaque is critical, as it is more vulnerable to rupture and serves as a powerful predictor of future cardiovascular events.
    • Carotid Intima Media Thickness (CIMT) , EndoPAT: Evaluate endothelial and arterial health

 

6. Microbiome and Detoxification Assessment

•         Stool Analysis assesses microbiota composition, inflammation, and β-glucuronidase activity, a key indicator of estrobolome function. Elevated enzyme levels suggest increased estrogen reactivation, contributing to estrogen dominance. It also identifies dysbiosis and guides microbiome-targeted therapies. β-glucuronidase elevation is often exacerbated by low-fiber/high-fat diets and gut dysbiosis—thus reversible.

•         Complete Hormone Test evaluates estrogen metabolism (2-OH, 4-OH, 16-OH pathways), adrenal function, and cortisol rhythms. Patterns of impaired detoxification may point to gut-liver axis dysfunction, especially when interpreted alongside stool analysis results.

•         Organic Acid and Stool Metabolomics detect microbial imbalances, nutrient deficiencies, and cardiometabolic risk markers like TMAO and butyrate. Low butyrate indicates reduced anti-inflammatory capacity and impaired gut barrier function.

7. Oral Health

    • Periodontal disease assessment by biologic or holistic dentists. 

8.  Micronutrients: Vitamin D, B-complex, omega-3s, magnesium,

                         Zinc and selenium (immune-thyroid-antioxidant triad),

 Iron studies (ferritin, transferrin saturation)—menopausal women often exhibit dysregulated iron metabolism linked to oxidative stress.

9. Autoimmunity & Detoxification: ANA, Gamma Glutamyl Transferase (GGT), homocysteine, albumin-creatinine ratio

10. Genetics: ApoE, MTHFR polymorphisms

11. The Role of Digital Biomarkers: CGM, HRV, and Beyond

In modern integrative cardiology, wearable and digital diagnostics offer real-time, actionable insights. Continuous glucose monitors (CGMs) help identify glycemic variability, postprandial hyperinsulinemia, and reactive hypoglycemia—often missed by fasting glucose or HbA1c alone. In perimenopausal women, CGM data frequently reveals dysregulated glucose metabolism months before overt metabolic syndrome emerges.

Similarly, heart rate variability (HRV) monitoring provides a window into autonomic tone and recovery capacity. Lower HRV correlates with heightened sympathetic activity, impaired vagal tone, and increased cardiovascular event risk [7]. HRV, combined with wearable sleep metrics and fitness trackers, enables dynamic assessment of recovery, stress response, and circadian alignment—key variables during menopausal transition. Nighttime HRV and CGM patterns correlate with sleep architecture and early glycemic dysfunction.

Digital data bridges the gap between clinical encounters and daily lived physiology. When integrated with labs, imaging, and patient-reported outcomes, tools like CGM and HRV enable continuous, individualized risk profiling.

 

KEY THERAPEUTIC PILLARS: FROM MOLECULES TO MOVEMENT

1. Lifestyle and Risk Modification: The Evidence is Clear- A recent study [23] showed that women with high lifestyle adherence (non-smoking, optimal sleep, regular exercise, healthy diet, less sitting) had:

    • 23% lower odds of CVD overall

    • 52% lower odds of CVD if they had premature menopause

    a.   Restorative sleep (7–8 hours) is essential for regulating blood pressure, cortisol levels, and cardiometabolic function.

    b.   Evidence-based stress management strategies like mindfulness, yoga, breathing exercises, and biofeedback improve heart rate variability and reduce cardiovascular events.

    c. Exercise Prescription

    • Resistance Training: 2–3x/week to counteract sarcopenia and improve insulin sensitivity [12]
    • Zone 2 Cardio: 150 minutes/week for mitochondrial and endothelial health
• VO₂max Tracking: Predictive of cardiovascular and overall mortality

    d. Precision Nutrition

    • Mediterranean diet with added protein (~1 g/lb ideal body weight)
    • Anti-inflammatory foods (omega-3s, polyphenols, fermented fibers)
    • Time-restricted eating and CGM-guided meal timing

3. TARGETED SUPPLEMENTATION

    • CoQ10: Mitochondrial and statin support
    • Omega-3s: Reduce triglycerides and inflammation [16]
    • Magnesium: Supports blood pressure, insulin sensitivity, and HRV
    • Vitamin K2/D3: Prevent arterial calcification while supporting bone health
    • Berberine, curcumin, resveratrol: Modulate insulin, lipids, and inflammation
    • Glycocalyx and nitric oxide support

4. Biodentical Hormone Therapy (BHRT)

• Safest when started within 5–10 years of menopause
• Bioidentical testosterone, estradiol + micronized progesterone preferred
• Lowers Lp(a), improves endothelial function, and reduces central adiposity in select candidates [20]

5. GUT HEALTH OPTIMIZATION: 

• Prebiotic fibers and polyphenols
• Butyrate-producing probiotics

• Probiotics and Postbiotics
• Phase II liver detox support (glutathione, methylation cofactors)

 

THE FUNCTIONAL CARDIOLOGY MANDATE 

Cardiovascular disease in women does not begin with symptoms. Up to 90% of asymptomatic individuals show plaque on coronary CT angiography [6]. Early detection—via imaging, digital tracking, and advanced biomarkers—transforms prevention from reactive to proactive.

Digital tools like CGM and HRV quantify real-time physiological stress and recovery. Combined with biometrics (muscle mass, VO₂max, waist-to-hip ratio) and laboratory metrics, they enable longitudinal, precision-based interventions that shift the trajectory of cardiovascular aging.

Conclusion: Precision Prevention as the New Standard

Menopause is not a disease, but a signal to recalibrate care. Functional cardiology reframes this transition as an opportunity for metabolic reprogramming—one rooted in data, physiology, and personalization.

This blueprint—merging functional diagnostics, wearables, imaging, and targeted therapy—provides a comprehensive framework to prevent cardiovascular decline and foster resilience. When implemented early and systematically, it empowers women to reclaim control over their cardiometabolic destiny.

The heart is not merely an organ; it reflects whole-body health. And for women in midlife, it deserves a whole-body, systems-based approach to care.

About the Author : Dr. Hwaida Hannoush is an internist, noninvasive cardiologist and former NIH researcher, specializing in functional and integrative approaches to heart health. She is the founder of Precimed Clinic, where she empowers women to reverse heart disease by addressing root causes. With a strong foundation in both clinical practice and research, Dr. Hannoush bridges science with personalized care. (for more information, visit her website @ https://precimedclinic.com)

ABOUT THE AUTHOR

Dr. Hwaida Hannoush is an Internal Medicine provider in Lanham, Maryland. Dr. Hannoush is highly rated in 1 condition. Her top areas of expertise are Alstrom Syndrome, Sickle Cell Disease, Congenital Hemolytic Anemia, and Hemoglobinopathy. Her clinical research consists of co-authoring 11 peer reviewed articles. MediFind looks at clinical research from the past 15 years. She specializes in Women with strong family history of heart disease and those who are high-performers who want clarity, energy, and long-term resilience. (for more information, visit her website @ https://empowered-women-hearts.mn.co/

......

Beyond Hormones (part1): A Functional Blueprint for Cardiometabolic Health in Menopause

Menopause marks not just the end of reproductive capability but a profound cardiometabolic inflection point. While vasomotor symptoms (VMS) have long dominated the clinical conversation, emerging science demands a broader lens. More than 60 million U.S. women live with cardiovascular disease (CVD)—the leading cause of death among women. Yet fewer than half of cardiologists feel adequately prepared to assess cardiovascular risk in women [1]. This is more than a knowledge gap—it is a systemic failure in women’s preventive care.

The abrupt decline in estrogen during menopause affects far more than reproductive physiology. It disrupts lipid metabolism, impairs endothelial function, escalates vascular stiffness, heightens systemic inflammation, and drives insulin resistance and visceral adiposity [2–4]. Women who experience frequent or severe VMS face a 77% higher risk of developing CVD [5]. From a functional cardiology perspective, menopause is not a time for passive observation, it is a critical opportunity to detect and reverse early signs of cardiovascular aging.

ESTROGEN’S DECLINE AND THE CARDIOVASCULAR SYSTEM

The decline in estrogen during menopause initiates multiple adverse physiological shifts that significantly increase cardiovascular risk in women.

Lipid Metabolism: Estrogen has favorable effects on lipid profiles, promoting higher High Density Lipoproteins (HDL)  and lower Low Density Lipoprotein (LDL) levels. Post menopause, however, is characterized by increases in total cholesterol, LDL, triglycerides, and a decrease in HDL. This shift—partly due to loss of estrogen’s regulation of hepatic LDL receptors and its antioxidant properties—leads to elevated ApoB levels and a more atherogenic lipid environment. Estrogen therapy has been shown to reverse some of these changes, improving lipid parameters including reductions in LDL and Lp(a), and increases in HDL.

Vascular Function: Estrogen promotes endothelial health and vascular elasticity by enhancing nitric oxide availability. Its decline contributes to endothelial dysfunction and arterial stiffness, as evidenced by reduced carotid artery distensibility in postmenopausal women. These changes are linked to rising systolic blood pressure and a higher incidence of coronary artery calcium (CAC), independent of age—suggesting hormonal withdrawal alone can promote coronary calcification.

Inflammation: Estrogen also exerts anti-inflammatory effects by modulating cytokine production and reducing oxidative stress. With its loss, systemic inflammation increases, marked by elevated hs-CRP and other pro-inflammatory markers. Central adiposity, which commonly increases during menopause, further exacerbates this inflammatory state. Notably, elevated hs-CRP is a strong predictor of cardiovascular events in postmenopausal women, even when LDL is normal, underscoring the need for inflammation-specific risk assessment.

Glucose and Insulin Regulation: Estradiol plays a critical role in insulin sensitivity. Its decline contributes to increased visceral fat, insulin resistance, and higher HOMA-IR values, even in normoglycemic women. This metabolic shift leads to higher triglycerides, reduced HDL, and a rise in small dense LDL particles. These changes collectively amplify cardiometabolic risk and contribute to the emergence of metabolic syndrome. Midlife women are therefore at increased risk for type 2 diabetes and atherosclerosis, even in the absence of overt hyperglycemia.

Estrobolome and Estrogen Homeostasis:  The estrobolome regulates estrogen recycling via enterohepatic circulation. After hepatic conjugation and biliary excretion, estrogens can be reactivated in the gut by β-glucuronidase-producing bacteria, then reabsorbed systemically. In a healthy, balanced microbiome, this supports estrogen homeostasis. However, dysbiosis—characterized by loss of microbial diversity or overgrowth of β-glucuronidase-producing species—can disrupt estrogen levels, leading either to estrogen deficiency (due to excessive elimination) or estrogen dominance (due to excessive reactivation). These imbalances may exacerbate menopausal symptoms and contribute to increased cardiovascular risk.

Gut Microbiome, Inflammation, and Cardiovascular Risk: The gut microbiota also modulates systemic inflammation and cardiometabolic function. Certain microbial species metabolize dietary choline and carnitine into trimethylamine N-oxide (TMAO), a pro-atherogenic compound linked to a twofold increased risk of major adverse cardiovascular events. In parallel, gut barrier dysfunction ("leaky gut") enables translocation of lipopolysaccharides (LPS), which can trigger chronic low-grade inflammation and insulin resistance—key drivers of endothelial damage and plaque formation. Conversely, beneficial gut bacteria produce short-chain fatty acids (SCFAs) such as butyrate, which exert anti-inflammatory effects, enhance insulin sensitivity, and support vascular health. Notably, estradiol has been shown to promote gut microbial diversity, suggesting that estrogen withdrawal may diminish SCFA production and further accelerate metabolic dysfunction.

Hormones & Oral Health: Estrogen decline increases the risk of oral health disorders, including periodontal disease, dry mouth, and burning mouth syndrome. These changes also affect the oral mucosa and salivary composition, heightening susceptibility to infections and discomfort. Estrogen receptors in oral tissues explain the direct hormonal influence.

Both oral diseases (such as periodontal disease) and cardiovascular disease are influenced by inflammatory processes. Menopause is associated with increased inflammation, which can contribute to both oral and cardiovascular conditions. Periodontal disease, more prevalent post menopause, contributes to systemic inflammation and endothelial stress. Chronic gum inflammation increases CVD risk by up to 19% [21]. 

THE SHORTCOMINGS OF CONVENTIONAL RISK STRATIFICATION

Traditional cardiology remains anchored to risk factors counting cholesterol, blood pressure, diabetes, smoking. While helpful, this framework fails to capture the multisystem dysregulation at play in the menopausal transition. Functional cardiology instead addresses:

    • Endothelial dysfunction and glycocalyx degradation

    • Inflammation and oxidative stress

    • Sarcopenia and mitochondrial decline

    • Oral and gut-derived immune triggers

    • Estrogen-related changes in insulin sensitivity, appetite, and vascular tone

    • Subclinical atherosclerosis detectable only with advanced imaging

Critically, conventional risk calculators underestimate cardiovascular risk in women, especially during perimenopause and early post menopause [6]. Tools like coronary artery calcium (CAC) scoring, carotid intima-media thickness (CIMT), and EndoPAT testing provide early insight into vascular integrity and plaque burden. Advanced labs—ApoB, Lp(a), oxLDL, hsCRP, myeloperoxidase (MPO), and HOMA-IR—allow clinicians to move from population-based predictions to personalized prevention.

PART 2 of "Beyond Hormones" - (coming soon)

ABOUT THE AUTHOR

Dr. Hwaida Hannoush is an internist, noninvasive cardiologist and former NIH researcher, specializing in functional and integrative approaches to heart health. She is the founder of Precimed Clinic, where she empowers women to reverse heart disease by addressing root causes. With a strong foundation in both clinical practice and research, Dr. Hannoush bridges science with personalized care. (for more information, visit her website @ https://precimedclinic.com)